Compounds > 1-(5-isoquinolinesulfonyl)-2-methylpiperazine

1-(5-isoquinolinesulfonyl)-2-methylpiperazine and pyrazolanthrone

1-(5-isoquinolinesulfonyl)-2-methylpiperazine has been researched along with pyrazolanthrone in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bian, HJ; Ji, XP; Li, XX; Liu, XB; Zhang, J; Zhang, Y	1

Other Studies

1 other study(ies) available for 1-(5-isoquinolinesulfonyl)-2-methylpiperazine and pyrazolanthrone

Article	Year
Inhibition of the activity of Rho-kinase reduces cardiomyocyte apoptosis in heart ischemia/reperfusion via suppressing JNK-mediated AIF translocation. Clinica chimica acta; international journal of clinical chemistry, 2009, Volume: 401, Issue:1-2 Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Animals; Anthracenes; Apoptosis; Apoptosis Inducing Factor; Female; MAP Kinase Kinase 4; Myocardial Infarction; Myocytes, Cardiac; Protein Kinase Inhibitors; Rats; Rats, Wistar; Reperfusion Injury; rho-Associated Kinases	2009

Article

Year

Inhibition of the activity of Rho-kinase reduces cardiomyocyte apoptosis in heart ischemia/reperfusion via suppressing JNK-mediated AIF translocation.

Clinica chimica acta; international journal of clinical chemistry, 2009, Volume: 401, Issue:1-2

Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Animals; Anthracenes; Apoptosis; Apoptosis Inducing Factor; Female; MAP Kinase Kinase 4; Myocardial Infarction; Myocytes, Cardiac; Protein Kinase Inhibitors; Rats; Rats, Wistar; Reperfusion Injury; rho-Associated Kinases

2009